Smart pill bottles and video visits boost cancer drug adherence
NCT ID NCT04054557
First seen Feb 05, 2026 · Last updated Jun 19, 2026 · Updated 21 times
Summary
This study tested whether using telehealth (video visits with a doctor) and smart pill bottles can help breast cancer patients take their hormone therapy more consistently. 305 women and men with early-stage hormone receptor-positive breast cancer participated. The goal was to see if these tools improve adherence to daily anti-estrogen pills, which can reduce the risk of cancer coming back.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for STAGE IIA BREAST CANCER AJCC V6 AND V7 are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Jefferson Health - Asplundh Cancer Pavilion
Willow Grove, Pennsylvania, 19090, United States
-
Jefferson Health - Northeast
Torresdale, Pennsylvania, 19114, United States
-
Jefferson Health - South Jersey
Washington Township, New Jersey, 08080, United States
-
Methodist Hospital
Philadelphia, Pennsylvania, 19148, United States
-
Thomas Jefefrson University
Philadelphia, Pennsylvania, 19107, United States
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
telehealth (video visits with oncologist)
What this could lead to
If successful, this approach could help more breast cancer patients take their hormone therapy as prescribed, potentially reducing the risk of cancer recurrence.
What could go wrong
This is a completed phase II trial, so results are not yet widely confirmed. The intervention focuses on adherence, not on treating the cancer itself, so it may not improve outcomes for all patients.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.